Streetbeat News

Stock Prices

BHE

Benchmark Electronics (BHE) reported Q4 adjusted EPS of $0.58, surpassing the consensus estimate of $0.56. However, their quarterly sales of $691.35M fell short of the expected $707.50M, marking a 7.90% decrease from the previous year.

Portfolio Pulse from mahesh@benzinga.com

January 31, 2024 | 9:26 pm

CMPR

Cimpress (NASDAQ:CMPR) reported Q2 earnings with an EPS of $2.14, surpassing the estimate of $1.24 by 72.58%. Revenue increased by $76.16 million compared to the same period last year. The previous quarter's EPS beat resulted in a 1.08% share price increase the following day.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 9:25 pm

DGII

Digi Intl (NASDAQ:DGII) reported Q1 earnings with an EPS of $0.48, beating estimates by 9.09% but with a revenue decline of $3.22 million from the previous year. The company has a history of surpassing EPS estimates, which in the last quarter led to a 0.86% stock price increase the following day.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 9:25 pm

MXL

MaxLinear (NASDAQ:MXL) reported Q4 earnings with EPS of $0.01, meeting estimates, but revenue declined by $165.23 million year-over-year. Last quarter's EPS miss led to a 21.96% share price drop the following day. Historical earnings data shows fluctuating performance over the past year.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 9:25 pm

ARAY

Accuray (NASDAQ:ARAY) reported Q2 earnings with an EPS of $-0.1, missing estimates by 100% compared to the expected $-0.05. Revenue decreased by $7.52 million from the same period last year. In the previous quarter, Accuray beat EPS estimates but the share price fell by 2.56% the following day.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 9:25 pm

OLMA

Olema Pharmaceuticals has filed a prospectus related to the resale of up to 13.2 million shares of common stock held by selling stockholders. This filing indicates that current shareholders may be looking to sell a significant portion of their holdings.

Portfolio Pulse from Charles Gross

January 31, 2024 | 9:24 pm

NXT

Nextracker's stock price has increased following the release of their Q3 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 9:24 pm

ARAY

Accuray Incorporated (NASDAQ:ARAY) reported a larger than expected quarterly loss of $(0.10) per share, missing the consensus estimate of $(0.05) by 100%. This represents a significant decline from the $(0.02) per share loss in the same quarter last year. However, the company's quarterly sales of $107.24 million slightly exceeded expectations of $106.67 million, but still marked a 6.55% decrease from the previous year's sales of $114.76 million.

Portfolio Pulse from mahesh@benzinga.com

January 31, 2024 | 9:23 pm

MXL

MaxLinear (NASDAQ:MXL) reported Q4 adjusted EPS of $0.01, matching analyst estimates, but representing a 99.07% decrease from $1.07 per share a year ago. Sales were $125.35M, slightly above the $125.11M estimate, yet marked a 56.86% decrease from $290.59M in the same quarter last year.

Portfolio Pulse from totan@benzinga.com

January 31, 2024 | 9:23 pm

OGI

VFF

Canadian cannabis companies Organigram Holdings Inc. and Village Farms International, Inc. are expanding their presence in the European market. Organigram has shipped its first batch of dried flower to Germany's Sanity Group, while Village Farms has begun building its first indoor cannabis production facility in the Netherlands. The German Bundestag is considering a cannabis legalization initiative, which could further open the market. Organigram's stock closed higher, while Village Farms' stock closed lower on Wednesday.

Portfolio Pulse from Jelena Martinovic

January 31, 2024 | 9:22 pm